Response to Comments: Trigger Point Injections (TPI)

This record is a response-to-comments notice related to the Trigger Point Injections LCD L39671 and lists literature references and administrative dates, but does not include explicit coverage criteria, exclusions, documentation requirements, or frequency limits. For actionable coverage criteria and claim documentation rules, consult the full LCD L39671 and the final notice effective 3/31/2024.

"Document provided contains only a response-to-comments summary and literature references; it does not specify coverage indications, exclusions, required documentation for claims, or frequency limit..."

Sign up to see full coverage criteria, indications, and limitations.